CIDP


Also found in: Dictionary, Financial, Acronyms.
Related to CIDP: CIPD

CIDP

chronic inflammatory demyelinating polyneuropathy (CIDP)

a slowly progressive autoimmune neurological disorder with demyelination of the peripheral nerves and nerve roots, characterized by progressive weakness and impaired sensory function (loss of reflexes) in the limbs and enlargement of the peripheral nerves and usually by elevated protein in the cerebrospinal fluid. It occurs most commonly in young adults, particularly males. Presenting symptoms often include tingling or numbness of the digits, weakness of the limbs, hyporeflexia or areflexia, fatigue, and abnormal sensations. It is similar to Guillain-Barré syndrome but has a slower onset and lasts much longer.

polyneuropathy

(pol?e-noo-rop'a-the) [ poly- + neuropathy]
Any disease that affects multiple peripheral nerves.

acute inflammatory demyelinating polyneuropathy

Guillain-Barré syndrome.

acute inflammatory polyneuropathy

Guillain-Barré syndrome.

amyloid polyneuropathy

Polyneuropathy characterized by deposition of amyloid in nerves.

chronic inflammatory demyelinating polyneuropathy

Abbreviation: CIDP
A gradually progressing autoimmune muscle weakness in arms and legs caused by inflammation of the myelin sheath covering peripheral nerve axons. Demyelination slows or blocks conduction of impulses to muscles. Numbness and paresthesia may accompany or precede loss of motor function, which varies from mild to severe. Laboratory findings include elevated protein levels in the cerebrospinal fluid. The inflammatory damage involves not only phagocytes (neutrophils and macrophages), but also immune complexes and complement activation by myelin autoantigens. Immunosuppressive drugs are used to treat this illness. Plasma exchange therapy or infusions of immunoglobulins often are used first, to produce a remission. CIDP is considered to be a chronic counterpart to Guillain-Barré syndrome.

critical illness polyneuropathy

Abbreviation: CIP
A complication occurring in patients in intensive care in which failure to wean from mechanical ventilation is associated with distal limb weakness, loss of distal sensation from light touch or pinprick, and diminished reflexes; facial muscles and nerves are spared. Recovery typically occurs several weeks or months after resolution of the underlying disease. It is associated with the use of drugs, such as corticosteroids or paralytic agents, and neurological illnesses, such as Guillain-Barre syndrome.

diabetic polyneuropathy

Diabetic neuropathy.

familial amyloiditic polyneuropathy

An inherited form of amyloid polyneuropathy in which abnormal forms of transthyretin are deposited in nerves and brain tissue, making multiple nerves malfunction.

paraproteinemic polyneuropathy

Polyneuropathy due to excessive levels of immunoglobulin in the blood. The most commonly implicated immunoglobulins are IgM and IgG.

porphyric polyneuropathy

Polyneuropathy due to acute porphyria, characterized by pains and paresthesias in the extremities and by flaccid paralysis.

progressive hypertrophic polyneuropathy

Déjérine-Sottas disease.

chronic inflammatory demyelinating polyneuropathy

Abbreviation: CIDP
A gradually progressing autoimmune muscle weakness in arms and legs caused by inflammation of the myelin sheath covering peripheral nerve axons. Demyelination slows or blocks conduction of impulses to muscles. Numbness and paresthesia may accompany or precede loss of motor function, which varies from mild to severe. Laboratory findings include elevated protein levels in the cerebrospinal fluid. The inflammatory damage involves not only phagocytes (neutrophils and macrophages), but also immune complexes and complement activation by myelin autoantigens. Immunosuppressive drugs are used to treat this illness. Plasma exchange therapy or infusions of immunoglobulins often are used first, to produce a remission. CIDP is considered to be a chronic counterpart to Guillain-Barré syndrome.
See also: polyneuropathy
References in periodicals archive ?
Malik added: "Because nerve damage cannot currently be reversed in diabetic neuropathy it is very important that patients who have CIDP are correctly diagnosed and treated as early as possible so that we limit long-term nerve damage.
Based on the initial evidence in this case, the patient's symptoms could reasonably indicate a diagnosis of either leprosy or CIDP.
He gave two keynote presentations at this year's conference--one on pain and fatigue, which he describes as "very common but much under-appreciated features of GBS and CIDP" and the other about atypical forms of GBS and CIDP.
Based on these criteria, the diagnosis of CIDP may be categorized as possible, probable, or definite categories (See Table l).
Until now, there has been no FDA-approved dosing regimen for an effective course of intravenous immune globulin therapy to reduce neuromuscular disability and improve quality of life in patients with CIDP.
This application was based on data from the largest-ever randomized CIDP trial, PATH (Polyneuropathy and Treatment with Hizentra), which was completed in March
The Provincial Planning Unit, under the Provincial Permanent Secretary, will carry out a monitoring and coordination function of all activities under the CIDP in the Western Province while the District Planning Office, under the District Council, will be the focal point for
In the process of selection the following patients were excluded--Cervical myelopathy (7 patients), ataxic neuropathy duo to CIDP with M brand (1 patient), chronic inflammatory demyelinating polyneuropathy (2 patients), GBS with ataxic neuropathy (2 patients), GBS with ataxic neuropathy (2 patients), Tabes dorsalis (1 patient each).
The initial diagnosis was recently changed to a related and a similarly little-known condition - which presents the same symptoms - called CIDP (Chronic Inflammatory Demyelinating Polyneuropathy).